|Outcomes||ARR favouring salmeterol (95% CI)||NNT (CI)†|
|†Abbreviations defined in glossary; †CI calculated from data in article.|
|Any exacerbation||2.7% (0.4 to 5.04)||37 (20 to 233)|
|Moderate or severe exacerbation||2.4% (0.2 to 4.6)||41 (22 to 417)|
Review: addition of salmeterol leads to improved lung function and fewer exacerbations in symptomatic asthma
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of EBN.
View free sample issue >>
EBN Online Journal Club
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.